MicroRNA-193b regulates human ovarian cancer cell growth via targeting STMN1

Haiyan Li1, Yuping Xu1, Danni Zhao1

  • 1Department of Gynaecology, Shi Jia Zhuang The Third Hospital, Shijiazhuang, Hebei 050011, P.R. China.

Insights

microRNA-193b acts as a tumor suppressor in ovarian cancer by inhibiting cell growth and promoting cell death. Its down-regulation suggests potential as a diagnostic biomarker and therapeutic target for ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian cancer is a leading cause of cancer death in women, often diagnosed late due to lack of early symptoms.
  • Current early detection and treatment methods for ovarian cancer are limited, highlighting the need for novel therapeutic targets.
  • microRNAs (miRNAs) are key regulators in cellular processes and cancer development; miRNA-193b's role in ovarian cancer remains unclear.

Purpose of the Study:

  • To investigate the role of miRNA-193b in human ovarian cancer.
  • To determine if miRNA-193b expression is altered in ovarian cancer cells.
  • To explore the functional impact of miRNA-193b on ovarian cancer cell proliferation and apoptosis.

Main Methods:

  • Quantitative reverse transcription PCR (RT-qPCR) to measure miRNA-193b expression levels.
  • Cell Counting Kit-8 (CCK-8) assay to assess cell proliferation.
  • Western blotting or similar techniques to analyze the expression of stathmin 1 (STMN1).

Main Results:

  • miRNA-193b expression was significantly reduced in human ovarian cancer cells compared to non-malignant cells.
  • Upregulation of miRNA-193b suppressed ovarian cancer cell proliferation and induced apoptosis.
  • Stathmin 1 (STMN1) was identified as a direct target of miRNA-193b, with its expression decreasing upon miRNA-193b upregulation.

Conclusions:

  • miRNA-193b functions as a tumor suppressor in ovarian cancer.
  • miRNA-193b inhibits ovarian cancer cell proliferation and promotes apoptosis, partly through targeting STMN1.
  • miRNA-193b holds promise as a potential diagnostic biomarker and therapeutic target for ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.0K